| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.009 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |